24Mar/14

Greater Effect on Disability Remains the Top Opportunity in Relapsing … – PR Newswire (press release)

Greater Effect on Disability Remains the Top Opportunity in Relapsing
PR Newswire (press release)
Clinical data and the opinions of interviewed thought leaders indicate that Lemtrada, Biogen Idec/AbbVie’s daclizumab, and Roche/Genentech’s ocrelizumab offer improvements in ARR over first-line injectable mainstays (e.g., Teva’s Copaxone). Surveyed …

and more »

24Mar/14

In Cigarroa's Wake, Major Gains and Significant Discord – MyHighPlains


MyHighPlains

In Cigarroa’s Wake, Major Gains and Significant Discord
MyHighPlains
And Francisco Cigarroa, a surgeon, will resume that career full time. Once his successor is installed later this year, Cigarroa, 56, will become the head of the pediatric transplant surgery unit at the UT Health Science Center at San Antonio, where he
Dr. Francisco Cigarroa looks back at his years as chancellorLaredo Morning Times

all 3 news articles »